As one of the birthplaces of the national orthopedic medical device industry and the primary hub for Zhangjiagang’s medical device sector, the Zhangjiagang Medical Device High-Tech Industrial Park has closely aligned itself with the “14th Five-Year Plan” development blueprint. By staying attuned to emerging trends in the medical field and continuously seizing development opportunities, the park has introduced specialized support policies for medical devices, established a dedicated industrial fund, and implemented targeted investment promotion efforts to achieve sustainable development. To date, over 50 medical device companies specializing in orthopedic implants and other high-end sectors—including Aide Technology,Aideer, Xinrong Bolt, Leikai Bio, Xieshu Bio, Kebang Gene, and Yonglan Bio, among more than 50 other entity enterprises specializing in orthopedic implants and other high-end medical devices. This has enabled the industry to expand from its existing full range of orthopedic implants—covering trauma, spine, and joints—into high-end sectors such as orthopedic new materials, minimally invasive treatments, in vitro diagnostic reagents, and medical aesthetics;Simultaneously, the park has attracted 120 medical device trade and service enterprises, including “Beijing Lidi Keke”—the nation’s largest medical device CRO platform—as well as Heraeus Bone Cement from Germany, the marketing headquarters of Beijing Natong Medical Group, and Sanfu Medical Group.
The Zhangjiagang Medical Device High-Tech Industrial Park, centered on the goal of building a “Thousand-Hundred-Ten” medical device industrial base, is deeply implementing a new full-industry-chain development model of “One Port, One Valley, One Center, One Platform, and One Base”—namely, the Innovation Port, Medical Aesthetics Valley, Testing Center,Medical Trade Platform, and Sterilization Base. This initiative strengthens and complements the high-end medical industry chain, building a high-end medical device industrial base that integrates R&D, incubation, testing, registration, production, sterilization, and trade. The goal is to create China’s most influential and distinctive “most comprehensive industrial chain” and “strongest industrial cluster,” with over 1,000 tenant enterprises, invoiced sales exceeding 10 billion yuan, and tax revenue exceeding 1.5 billion yuan.